Discovery Therapeutics

Focused on the discovery, development, and commercialization of compounds for the treatment of cardiorenal diseases. Discovery Therapeutics, Inc.'s product portfolio includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular diseases, as well as FLAP antagonists for the treatment of chronic kidney disease.